Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for $490 million. Piramal Pharma will use the capital injection to accelerate its organic and inorganic growth plans. This transaction is one of the largest private equity deals in the Indian pharmaceutical...
India's Piramal invest in Berlin Germany R&D
Mumbai-based Piramal Enterprises is continuing research and development work in Berlin on the PET (Positron Emission Tomography) technology it acquired from Bayer Healthcare earlier this year. The initiative wil lead to early detection of Alzheimer's disease. At a press briefing, Ajay Piramal, Chairman of the Piramal Group commented on the...